Cardinal Health CAO Scherer sells $1m in shares

Cardinal Health (CAH) reported mixed fourth-quarter fiscal 2025 results, with earnings per share of $2.08 exceeding expectations but revenue of $60.2 billion falling short. Concurrently, the company announced a $1 billion senior note offering and approved a quarterly dividend of $0.5107 per share, while Chief Accounting Officer Mary C. Scherer executed a sale of over $1 million in company stock. InvestingPro analysis indicates CAH is currently undervalued, supported by its 43-year dividend track record and a beta of 0.68, providing context for the mixed financial performance and insider transaction.

Analysis

Cardinal Health (CAH) presents a mixed financial profile based on its recent fourth-quarter fiscal 2025 results and corporate actions. The company demonstrated operational efficiency by exceeding earnings estimates with an EPS of $2.08 versus a $2.03 forecast, but simultaneously revealed top-line weakness with revenue of $60.2 billion falling short of the $60.92 billion expectation. This performance is set against a backdrop of significant capital activity, including a new $1 billion senior note offering and the reaffirmation of its commitment to shareholder returns via a $0.5107 quarterly dividend, extending its 43-year track record. A notable insider transaction involved the Chief Accounting Officer selling over $1 million in stock; however, the signal is partially diluted as a portion was a non-discretionary withholding for taxes and was accompanied by a new RSU grant. Despite these conflicting signals, the stock maintains defensive characteristics, evidenced by a low beta of 0.68, and analyst price targets between $150 and $203 suggest it is currently undervalued.

Key Decisions for Investors

• Investors focused on income and defensive positioning may find CAH's consistent dividend, recently reaffirmed, and low beta of 0.68 attractive, particularly as analyst consensus points to the stock being undervalued.
• The Q4 revenue miss is a key concern, and investors should closely monitor future top-line growth trends to ensure the recent earnings outperformance is sustainable.
• While the Chief Accounting Officer's sale has mitigating factors, it warrants observation; further insider selling could signal a more cautious internal outlook on the company's growth prospects.